naproxen (Q1215575)

NAPROXEN (English)

19 October 2016

1976

1 reference

https://hmdb.ca/metabolites/HMDB0001923

1 reference

C₁₄H₁₄O₃

1 reference

NAPROXEN (English)

19 November 2016

CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O

1 reference

NAPROXEN (English)

19 November 2016

C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O

1 reference

NAPROXEN (English)

19 November 2016

155 degree Celsius

1 reference

Jean-Claude Bradley Open Melting Point Dataset

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

Midol Extended Relief

1 reference

14 February 2018

1 reference

14 February 2018

World Health Organisation international non-proprietary name

naproxen (English)

1 reference

Isolation of (S)-(+)-naproxene from Musa acuminata. Inhibitory effect of naproxene and its 7-methoxy isomer on constitutive COX-1 and inducible COX-2.

naproxen (English)

19 October 2016

1 reference

Plantago major

1 reference

Ursolic acid from Plantago major, a selective inhibitor of cyclooxygenase-2 catalyzed prostaglandin biosynthesis

medical condition treated

1 reference

juvenile rheumatoid arthritis

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

ankylosing spondylitis

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

osteoarthritis susceptibility 1

13 December 2016

1 reference

2 October 2018

migraine

1 reference

2 October 2018

fibromyalgia

1 reference

2 October 2018

gout

1 reference

2 October 2018

medial epicondylitis

1 reference

significant drug interaction

2 October 2018

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clopidogrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eptifibatide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

iloprost

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prostacyclin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tirofiban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

abciximab

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prasugrel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ticagrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cangrelor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pemetrexed

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fondaparinux

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenindione

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivaroxaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apixaban

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enoxaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dalteparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinzaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

budesonide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enoxaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dalteparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinzaparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eprosartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heparin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olmesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

azilsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(S)-duloxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bumetanide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

furosemide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenofovir disoproxil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pemetrexed

bone marrow failure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pemetrexed

gastrointestinal toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

leukopenia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

thrombocytopenia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

anemia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mouth ulcer

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bendroflumethiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorthalidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(2RS,6RS)-clopamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bumetanide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

furosemide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indapamide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

valsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

telmisartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eprosartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eprosartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

irbesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

candesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

losartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olmesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olmesartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

azilsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

azilsartan

1 reference

A reference set of clinically relevant adverse drug-drug interactions

eplerenone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

triamterene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

spironolactone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiloride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methylprednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisolone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prednisone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

betamethasone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

budesonide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenofovir disoproxil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Prostaglandin-endoperoxide synthase 1

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Prostaglandin-endoperoxide synthase 2

17 August 2016

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Prostaglandin-endoperoxide synthase 1

17 August 2016

reaction inhibitor

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL154

Prostaglandin-endoperoxide synthase 2

reaction inhibitor

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL154

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category C

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

cyclooxygenase inhibitors

2 references

5 March 2018

Medical Subject Headings

MeSH descriptor ID

D009288

non-steroidal anti-inflammatory drug

15 March 2018

1 reference

InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

2918.99.40

0 references

Commons category

Naproxen

0 references

Identifiers

InChI

1 reference

NAPROXEN (English)

19 November 2016

2 references

NAPROXEN (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

22204-53-1

2 references

naproxen (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=22204-53-1

8 April 2021

1 reference

Naproxen (English)

19 November 2016

2 references

NAPROXEN (English)

19 November 2016

Reaxys registry number

3591067

1 reference

naproxen (English)

19 October 2016

mapping relation type

3 references

NAPROXEN (English)

19 November 2016

ChEBI release 2019-10-02

International Chemical Identifier

InChI

InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1

1 reference

NAPROXEN (English)

19 November 2016

2 references

inferred from InChIKey

splash10-00di-0900000000-e7dfead967f29853140d

1 reference

MassBank accession ID

MSBNK-Keio_Univ-KO009075

0 references

MSBNK-Keio_Univ-KO009076

0 references

MSBNK-Keio_Univ-KO001523

0 references

MSBNK-Keio_Univ-KO001524

0 references

MSBNK-Keio_Univ-KO001525

0 references

MSBNK-Keio_Univ-KO001526

0 references

MSBNK-Keio_Univ-KO001527

0 references

MSBNK-Waters-WA000355

0 references

MSBNK-Waters-WA000356

0 references

MSBNK-Waters-WA000357

0 references

MSBNK-Waters-WA000358

0 references

MSBNK-Waters-WA000359

0 references

MSBNK-Waters-WA000360

0 references

MSBNK-Waters-WA000361

0 references

SPLASH

0 references

splash10-01b9-0900000000-f5f45cee188a08ef62b1

0 references

splash10-014i-0900000000-6c076658da1c69f1b909

0 references

splash10-014i-0900000000-2e1269f26d5b927bca33

0 references

splash10-000i-0900000000-b913db958cba90673250

0 references

splash10-00di-0900000000-14f7289bbafe9f05ed62

0 references

splash10-001i-0190000000-64cc22cce1238357760e

0 references

splash10-0f79-0900000000-17f4e93fda31d93027a1

0 references

splash10-0fr6-0900000000-4dd08568cff27d62d867

0 references

NMRShiftDB structure ID

20209411

1 reference

HSDB ID

3369

1 reference

Hazardous Substances Data Bank

28 October 2019

NAPROXEN (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

naproxen (English)

ECHA Substance Infocard ID

19 November 2016

100.040.747

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Naproxen (English)

CAS no.: 22204-53-1 (English)

1 reference

28 December 2019

NAPROXEN (English)

CAS no.: 22204-53-1 (English)

1 reference

Naproxen (English)

17 November 2015

1 reference

Naproxen (English)

17 November 2015

1 reference

Naproxen (English)

publication date

17 November 2015

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

D02.455.426.559.847.638.472.500

naproxen (English)

19 November 2016

Naproxen

0 references

MeSH concept ID

M0014467

0 references

MeSH tree code

0 references

0 references

1 reference

naproxen (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0001923

2 references

based on heuristic

inferred from InChIKey

2 references

naproxen (English)

19 November 2016

MedlinePlus drug identifier

0 references

1 reference

naproxen (English)

19 November 2016

0 references

1 reference

1 reference

naproxen (English)

19 October 2016

1 reference

Immune Epitope Database and Analysis Resource

naproxen (English)

19 October 2016

1 reference

1 March 2022

0 references

1 reference

28 October 2013

Interlingual Index ID

0 references

1 reference

9 July 2020

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

4JQ1 (English)

19 October 2016

1 reference

3NT1 (English)

19 October 2016

1 reference

4FJP (English)

19 October 2016

1 reference

5DBY (English)

19 October 2016

1 reference

3R58 (English)

19 October 2016

1 reference

4OT2 (English)

19 October 2016

1 reference

4ZBR (English)

19 October 2016

1 reference

4PO0 (English)

19 October 2016

1 reference

2VDB (English)

19 October 2016

1 reference

UK Parliament thesaurus ID

4OR0 (English)

19 October 2016

1 reference

451460

subject named as

Naproxen

0 references

UMLS CUI

C0027396

1 reference

naproxen (English)

19 November 2016

0 references

0 references

WordNet 3.1 Synset ID

03813435-n

1 reference

naprokseeni

naproxen

1 reference

YSO-Wikidata mapping project